Summary – -The Indian Institute of Science (IISc) department of Microbiology and Cell Biology (MCB) and the Centre for Infectious Disease Research…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
India
-
-
IndiaPharma Science & Research
COVID-19: India supplies 5 lakh more Covaxin doses to Afghanistan
by adminby adminSynopsis: Bharat Biotech on Monday informed that India has supplied another batch of humanitarian assistance consisting of 5,00,000 doses of COVID-19 vaccine,…
-
CompaniesMolnupiravirSun Pharma
Sun Pharma arm receives DCGI approval for Molnupiravir in India
by adminby adminSynopsis : – Sun Pharmaceutical Industries Limited announced that one of its wholly owned subsidiaries has received Emergency Use Authorization (EUA) from…
-
AgrochemicalsIndiaLaunch
Torrent Pharma to launch Molnupiravir under the Brand Name Molnutor in India
by adminby adminSynopsis: Torrent Pharma announced that it is introducing MSD (a trade name of Merck & Co., Inc, Kenilworth, New Jersey, USA) and…
-
AgrochemicalsIndia
Health ministry extends date of implementation of UDI for medical devices
by adminby adminSummary : -The ministry of health and family welfare has decided to extend the date of implementation of the unique device identification…
-
After skipping two years due to the Covid-19 pandemic, the pharmaceutical industry in Chennai is getting ready to host the seventh edition…
-
RegulatorySun PharmaU.S FDA
USFDA Approves Generic Amphotericin B Liposome for Injection Manufactured By Sun Pharma
by adminby adminSynopsis- Sun Pharmaceuticals Industries announced that one of its wholly-owned subsidiaries has received final approval from US FDA for its Abbreviated New…
-
Synopsis: The development has come at a time when the Omicron variant is making its presence felt in various states, with at…
-
Synopsis – – Vineet Gupta joined Eli Lilly in 2010 as Marketing Director for India, followed by a role as Corporate Affairs…
-
Agro Science & ResearchTGAZydus Cadila
TGA Gives Clear Signal To Zydus nod to conduct Phase II clinical study in patients with CAPS – Aus
by adminby adminSynopsis- Zydus announced today that it has received permission to initiate the Phase II (a) clinical study of its NLRP3 inhibitor “ZYIL1”…